| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5916560 |
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
Jun. 29, 1999 |
| 5916871 |
Inhibitory factor |
Jun. 29, 1999 |
| 5916873 |
Teicoplanin derivatives |
Jun. 29, 1999 |
| 5914312 |
Pretargeting methods and compounds |
Jun. 22, 1999 |
| 5914316 |
Method of inhibiting intimal hyperplasia |
Jun. 22, 1999 |
| 5910309 |
UV-induced factor for immunosuppression |
Jun. 8, 1999 |
| 5910481 |
Hybrid proteins with modified activity |
Jun. 8, 1999 |
| 5908826 |
Freeze-dried preparation containing monoclonal antibody |
Jun. 1, 1999 |
| 5908835 |
Anti-tumor compositions containing taxane derivatives |
Jun. 1, 1999 |
| 5902585 |
Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists |
May. 11, 1999 |
| 5902785 |
Cartilage induction by bone morphogenetic proteins |
May. 11, 1999 |
| 5895646 |
Isolated native primate GM-CSF protein |
Apr. 20, 1999 |
| 5895647 |
Use of oral interleukin-6 as therapy for hemorrhagic shock |
Apr. 20, 1999 |
| 5891438 |
Method for stimulating production of variable region gene family restricted antibodies through B-cell superantigen vaccination |
Apr. 6, 1999 |
| 5888495 |
Method of producing storage stable M-CSF lyophilizates |
Mar. 30, 1999 |
| 5888964 |
Method for increasing placental blood flow |
Mar. 30, 1999 |
| 5888968 |
TFPI formulation |
Mar. 30, 1999 |
| 5888969 |
Use of cytokine restraining agents to treat inflammatory bowel disease |
Mar. 30, 1999 |
| 5888978 |
Method for reducing the severity of gastro-intestinal damage |
Mar. 30, 1999 |
| 5888988 |
Covalently linked N,O-carboxymethylchitosan and uses thereof |
Mar. 30, 1999 |
| 5883073 |
Single-chain double-alpha peptide |
Mar. 16, 1999 |
| 5883074 |
Potentiators of antibacterial agents |
Mar. 16, 1999 |
| 5879672 |
Tie-2 ligand 1 |
Mar. 9, 1999 |
| 5879681 |
Compounds and compositions for delivering active agents |
Mar. 9, 1999 |
| 5880091 |
Glycoprotein ligand for P-selectin and methods of use thereof |
Mar. 9, 1999 |
| 5880333 |
Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
Mar. 9, 1999 |
| 5876710 |
Compounds and compositions for delivering active agents |
Mar. 2, 1999 |
| 5876724 |
Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
Mar. 2, 1999 |
| 5877147 |
Compounds for medicinal use |
Mar. 2, 1999 |
| 5877148 |
Treatment of cancer with human chorionic gonadotropin |
Mar. 2, 1999 |
| 5877149 |
Deepithelialized skin diffusion cell system |
Mar. 2, 1999 |
| 5874401 |
Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis |
Feb. 23, 1999 |
| 5871723 |
CXC chemokines as regulators of angiogenesis |
Feb. 16, 1999 |
| 5871734 |
Treatment for asthma with VLA-4 blocking agents |
Feb. 16, 1999 |
| 5871735 |
Isoferritin as a marker for pathological pregnancy |
Feb. 16, 1999 |
| 5872095 |
IL-1 receptor antagonists medicaments |
Feb. 16, 1999 |
| 5872096 |
Modified sialyl Lewis.sup.a compounds |
Feb. 16, 1999 |
| 5869049 |
Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
Feb. 9, 1999 |
| 5869446 |
Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections |
Feb. 9, 1999 |
| 5869449 |
38-decarboxy-38-hydroxymethyl derivatives of teiocoplanin antibiotics and a process for preparing them |
Feb. 9, 1999 |
| 5869457 |
Modified proteins and their use for controlling viral infections |
Feb. 9, 1999 |
| 5863528 |
Porcine cytokines |
Jan. 26, 1999 |
| 5863804 |
Antibodies specifically reactive with T-cadherin |
Jan. 26, 1999 |
| 5863896 |
Evaluation of substances for altering and for increasing APC response |
Jan. 26, 1999 |
| 5863897 |
Synducin mediated modulation of tissue repair |
Jan. 26, 1999 |
| 5861159 |
Controlled release of pharmaceutically active substances for immunotherapy |
Jan. 19, 1999 |
| 5861374 |
Modified Factor VII |
Jan. 19, 1999 |
| 5858969 |
Therapeutic methods employing sialylated glycoforms of soluble complement receptor 1 (SCR 1) |
Jan. 12, 1999 |
| 5858970 |
Polypeptide having Factor Xa inhibitory activity |
Jan. 12, 1999 |
| 5855919 |
Method using keyhole limpet hemocyanin composition with enhanced immunogenic activity |
Jan. 5, 1999 |
|
|
|
